OBJECTIVE: To describe our institutional experience in the management of infants and children with pertussis admitted during a 20-yr period (January 1985 through December 2004) and also to study the relation between method of presentation and outcome. SETTING: Pediatric intensive care unit in a university-affiliated tertiary pediatric hospital in Melbourne, Australia. DESIGN/ METHODS: Retrospective review of medical records and radiology reports of patients with a diagnosis of pertussis identified from the pediatric intensive care unit database. RESULTS: A total of 49 patients (median age, 6 wks; interquartile range, 4-8 wks) required 55 admission episodes to the pediatric intensive care unit. Main reasons for admission were apnea with or without cough paroxysms (63%), pneumonia (18%), and seizures (10%). None of the infants had completed the primary course of immunization, and 94% had not received a single dose of pertussis vaccine. Infants presenting with pneumonia presented earlier (p = .001), had longer intensive care stay (p = .007), higher white cell count (p < or = .001), lower Pao2 at admission (p = .020), and higher mortality. Six infants out of seven needing circulatory support died (including all four treated with extracorporeal membrane oxygenation), and all deaths (n = 7) occurred in infants who had pneumonia at presentation. CONCLUSION: Patients with pertussis, presenting as apnea (with or without cough paroxysms), treated in the pediatric intensive care unit had 100% survival. However, pneumonia as the main reason for admission and the need for circulatory support is associated with a very poor outcome. A deeper understanding of the molecular basis of Bordetella pertussis and its relation to the human host might offer means for future therapies.
OBJECTIVE: To describe our institutional experience in the management of infants and children with pertussis admitted during a 20-yr period (January 1985 through December 2004) and also to study the relation between method of presentation and outcome. SETTING: Pediatric intensive care unit in a university-affiliated tertiary pediatric hospital in Melbourne, Australia. DESIGN/ METHODS: Retrospective review of medical records and radiology reports of patients with a diagnosis of pertussis identified from the pediatric intensive care unit database. RESULTS: A total of 49 patients (median age, 6 wks; interquartile range, 4-8 wks) required 55 admission episodes to the pediatric intensive care unit. Main reasons for admission were apnea with or without cough paroxysms (63%), pneumonia (18%), and seizures (10%). None of the infants had completed the primary course of immunization, and 94% had not received a single dose of pertussis vaccine. Infants presenting with pneumonia presented earlier (p = .001), had longer intensive care stay (p = .007), higher white cell count (p < or = .001), lower Pao2 at admission (p = .020), and higher mortality. Six infants out of seven needing circulatory support died (including all four treated with extracorporeal membrane oxygenation), and all deaths (n = 7) occurred in infants who had pneumonia at presentation. CONCLUSION:Patients with pertussis, presenting as apnea (with or without cough paroxysms), treated in the pediatric intensive care unit had 100% survival. However, pneumonia as the main reason for admission and the need for circulatory support is associated with a very poor outcome. A deeper understanding of the molecular basis of Bordetella pertussis and its relation to the human host might offer means for future therapies.
Authors: D Dilli; I Bostanci; Y Dallar; T Buzgan; H Irmak; M A Torunoğlu Journal: Eur J Clin Microbiol Infect Dis Date: 2008-01-09 Impact factor: 3.267
Authors: Julie H Shakib; Lisa Wyman; Per H Gesteland; Catherine J Staes; D W Bennion; Carrie L Byington Journal: J Public Health Manag Pract Date: 2009 Nov-Dec
Authors: Jeri S Burr; Tammara L Jenkins; Rick Harrison; Kathleen Meert; K J S Anand; John T Berger; Jerry Zimmerman; Joseph Carcillo; J Michael Dean; Christopher J L Newth; Douglas F Willson; Ronald C Sanders; Murray M Pollack; Eric Harvill; Carol E Nicholson Journal: Pediatr Crit Care Med Date: 2011-07 Impact factor: 3.624
Authors: John T Berger; Joseph A Carcillo; Thomas P Shanley; David L Wessel; Amy Clark; Richard Holubkov; Kathleen L Meert; Christopher J L Newth; Robert A Berg; Sabrina Heidemann; Rick Harrison; Murray Pollack; Heidi Dalton; Eric Harvill; Alexia Karanikas; Teresa Liu; Jeri S Burr; Allan Doctor; J Michael Dean; Tammara L Jenkins; Carol E Nicholson Journal: Pediatr Crit Care Med Date: 2013-05 Impact factor: 3.624
Authors: Varun K Phadke; John P McCracken; Jennifer L Kriss; Maria R Lopez; Kim A Lindblade; Joe P Bryan; Miguel E Garcia; Carlos E Funes; Saad B Omer Journal: J Pediatric Infect Dis Soc Date: 2018-12-03 Impact factor: 5.235
Authors: John T Berger; Michele E Villalobos; Amy E Clark; Richard Holubkov; Murray M Pollack; Robert A Berg; Joseph A Carcillo; Heidi Dalton; Rick Harrison; Kathleen L Meert; Christopher J L Newth; Thomas P Shanley; David L Wessel; Kanwaljeet J S Anand; Jerry J Zimmerman; Ronald C Sanders; Teresa Liu; Jeri S Burr; Douglas F Willson; Allan Doctor; J Michael Dean; Tammara L Jenkins; Carol E Nicholson Journal: Pediatr Crit Care Med Date: 2018-02 Impact factor: 3.624